RxDoctor Payments Data

Eric Lavonas, MD

Medical Toxicology · Denver, CONPI 1710914007

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $37,614 of the $40,434 with a category attached, or 93.0%. BTG International Inc. accounts for 99.9% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2019 at $25,264 and has fallen 92.3% since, to $1,945 in 2022.

$40,434in general payments, 2019–2025

Across 16 payments — averaging $2527.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • BTG International Inc.$40K
  • Impulse Dynamics (USA) Inc.$38
$69,546in research payments, 2019–2025

Across 3 payments — averaging $23,182 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • BTG International Inc.$70K

What the payments were for

  • Speaking & faculty fees$37,61493%
  • Travel & lodging$2,4226%
  • Food & beverage$3971%

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
BTG International Inc.15$40,396
Impulse Dynamics (USA) Inc.1$38

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few medical toxicology providers in Coloradoto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$16,269
Medicare patients
103
Services billed
113

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other medical toxicology in Denver

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →